3.4.1.0: Antihistamines

Part of chapter 3 Respiratory System, section 3.4 Antihistamines, hyposensitisation and allergic emergencies

High-level prescribing trends for Antihistamines (BNF section 3.4.1.0) across Tower Hill Partnership for the last five years. You can explore prescribing trends for this section by Sub-ICB Location, or learn more about this site.

View all matching dm+d items.

No prescriptions found.

Do you need help with your analysis? Don't forget to check the FAQ page, and get in touch if you have questions.

Chemicals

Acrivastine (0304010A0)
Alimemazine tartrate (0304010Y0)
Azatadine maleate (0304010C0)
Bilastine (0304010AF)
Brompheniramine maleate (0304010F0)
Cetirizine hydrochloride (0304010I0)
Chlorphenamine maleate (0304010G0)
Clemastine fumarate (0304010H0)
Cyproheptadine hydrochloride (0304010K0)
Desloratadine (0304010AB)
Diphenhydramine hydrochloride (0304010N0)
Fexofenadine hydrochloride (0304010E0)
Hydroxyzine hydrochloride (0304010J0)
Ketotifen fumarate (0304010AG)
Levocetirizine (0304010AC)
Loratadine (0304010D0)
Mizolastine (0304010AA)
Promethazine hydrochloride (0304010W0)
Rupatadine fumarate (0304010AE)
Terfenadine (0304010X0)
Feedback